George Mason University

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

The Institute for Biohealth Innovation

George Mason University

Institute for Biohealth Innovation, George Mason University, 4400 University Drive, Fairfax, VA 22030

https://ibi.gmu.edu/

Patents

Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto

2025-06-17 • US-12331096-B2

Systems and methods for facilitating navigation in space

2025-03-18 • US-12254574-B2

Compositions and methods for modulation of extracellular vesicle release and treatment of neurological disorders

2025-01-28 • US-12208080-B2

Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions

2025-01-14 • US-12194087-B2

Molecularly imprinted particles

2024-10-01 • US-12105092-B2

Exertion-aware path generation

2024-10-01 • US-12102910-B2

What We Do

Health and Wellness Clinics

The MAP Clinics serve uninsured, immigrant, and refugee communities, providing healthcare, screenings, and mental health services.

SMART Lab

A state-of-the-art facility for neuromechanical assessment and research on traumatic brain injury and other health-related studies.

Research Areas

IBI conducts research in various areas including brain and behavior, cancer, cardiovascular health, and infectious diseases.

Psychological and Cognitive Health and Performance

Objective Behavioral Health Assessment and Monitoring

Cross-Cutting Prevention

Postventions for Suicide

Digital Health Technologies

Medical Decision Assistance

Personalized Medicine

Diagnostics

Pathology (Biopsies and Blood Tests)

Biologics

Recombinant Proteins

Cellular Therapy

RNA Interference (RNAi)

Application Area

Musculoskeletal Rehabilitation

Musculoskeletal Injury Prevention, Treatment, and rehabilitation

Physiological Health Monitoring and Performance

Services

Good Laboratory Practices

Clinical Research Organizations (CRO)

Preclinical Development

Vaccines

Immunization Delivery Approaches

Attenuated Vaccines

Conjugate Vaccines

Routes of Administration

Mucosal/Sublingual

Medical Devices

Non-FDA Regulated Medical Devices

Drugs

Large Molecule Drugs

Small Molecule Drugs

Infectious Diseases

Antibiotic Resistance

Sepsis Management

Battlefield Resuscitation

Hemorrhage Control

Resuscitation and Stabilization Technology

Regenerative Medicine

Compartment Syndrome

Craniomaxillofacial

Key People

Amy Adams

Executive Director, Institute for Biohealth Innovation

Andre Marshall

Vice President for Research, Innovation, and Economic Impact

Rebekah Hersch

Associate Vice President for Research and Innovation

Funded Projects

SMART-US Wearable Ultrasound + AI Device for Muscle Force Prediction

AI-powered ultrasound in a wearable—SMART-US delivers lab-grade muscle-force insights anywhere.

News & Updates

Bio & Beer

An event hosted by the Northern Virginia BioHub for networking among biotech professionals.

A Population Genomics Approach to Understand Norovirus Emergence and Immunity

Talk by Dr. Gabriel Parra on Norovirus research.

Bioengineering alumna completes a fun(gal) summer internship with NIH

Highlighting the experience of a bioengineering student at NIH.

How nano roughness could smooth out clotting risks

Research on the impact of nano roughness on medical devices.